66 related articles for article (PubMed ID: 22851403)
1. HCCRBP-3 induces tumorigenesis through direct interaction with HCCR-1 in human cancers.
Ha SA; Kim HK; Yoo JA; Kim S; Shin SM; Gong GH; Lee YK; Kim JW
Mol Carcinog; 2014 Jan; 53(1):30-7. PubMed ID: 22851403
[TBL] [Abstract][Full Text] [Related]
2. HCCRBP-1 directly interacting with HCCR-1 induces tumorigenesis through P53 stabilization.
Ha SA; Shin SM; Lee YJ; Kim S; Kim HK; Namkoong H; Lee H; Lee YS; Cho YS; Park YG; Jeon HM; Oh C; Kim JW
Int J Cancer; 2008 Feb; 122(3):501-8. PubMed ID: 17943721
[TBL] [Abstract][Full Text] [Related]
3. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression.
Cho GW; Shin SM; Namkoong H; Kim HK; Ha SA; Hur SY; Kim TE; Chai YG; Kim JW
Gene; 2006 Dec; 384():18-26. PubMed ID: 16949218
[TBL] [Abstract][Full Text] [Related]
5. HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.
Shin SM; Chung YJ; Oh ST; Jeon HM; Hwang LJ; Namkoong H; Kim HK; Cho GW; Hur SY; Kim TE; Lee YS; Park YG; Ko J; Kim JW
Gastroenterology; 2006 Jun; 130(7):2074-86. PubMed ID: 16762630
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.
Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW
Oncogene; 2004 Mar; 23(10):1950-3. PubMed ID: 14691448
[TBL] [Abstract][Full Text] [Related]
7. Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status.
Ha SA; Lee YS; Shin SM; Kim HK; Kim S; Namkoong H; Kim HJ; Jung SM; Lee YS; Chung YJ; Jung SS; Kim JW
BMC Cancer; 2009 Feb; 9():51. PubMed ID: 19208263
[TBL] [Abstract][Full Text] [Related]
8. The HCCR oncoprotein as a biomarker for human breast cancer.
Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
[TBL] [Abstract][Full Text] [Related]
9. [The inhibition effect and its molecular mechanism of human cervical cancer oncogene siRNA on hepatocarcinoma cells].
Yang Y; Zhou XF; Liu AD
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):612-5. PubMed ID: 18752750
[TBL] [Abstract][Full Text] [Related]
10. TCF/beta-catenin plays an important role in HCCR-1 oncogene expression.
Cho GW; Kim MH; Kim SH; Ha SA; Kim HK; Kim S; Kim JW
BMC Mol Biol; 2009 May; 10():42. PubMed ID: 19435525
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
Luke JJ; Van De Wetering CI; Knudson CM
Cell Death Differ; 2003 Jun; 10(6):740-8. PubMed ID: 12761582
[TBL] [Abstract][Full Text] [Related]
12. [HCCR-2 enhances the division and proliferation of SMMC 7721 via PI3K/Akt pathway].
Yang YM; Qian JB; Hao B; Zhang GX
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):837-41. PubMed ID: 21138632
[TBL] [Abstract][Full Text] [Related]
13. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
14. Transdifferentiation-inducing HCCR-1 oncogene.
Ha SA; Kim HK; Yoo J; Kim S; Shin SM; Lee YS; Hur SY; Kim YW; Kim TE; Chung YJ; Jeun SS; Kim DW; Park YG; Kim J; Shin SY; Lee YH; Kim JW
BMC Cell Biol; 2010 Jun; 11():49. PubMed ID: 20591135
[TBL] [Abstract][Full Text] [Related]
15. The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.
Luu Y; Bush J; Cheung KJ; Li G
Exp Cell Res; 2002 Jun; 276(2):214-22. PubMed ID: 12027451
[TBL] [Abstract][Full Text] [Related]
16. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
[TBL] [Abstract][Full Text] [Related]
17. Destabilization of CARP mRNAs by aloe-emodin contributes to caspase-8-mediated p53-independent apoptosis of human carcinoma cells.
Lin ML; Lu YC; Su HL; Lin HT; Lee CC; Kang SE; Lai TC; Chung JG; Chen SS
J Cell Biochem; 2011 Apr; 112(4):1176-91. PubMed ID: 21308745
[TBL] [Abstract][Full Text] [Related]
18. Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer.
Chung YJ; Kim JW
Histol Histopathol; 2005 Jul; 20(3):999-1003. PubMed ID: 15944950
[TBL] [Abstract][Full Text] [Related]
19. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
20. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]